Christoph Nonnenbroich

Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 Inhibitors

T. Decker, K. Geiger, T. Dechow, 2022, Oncology Research and Treatment.

Elective Discontinuation of CDK4/6 Inhibitors in Patients with Metastatic Hormone Receptor-Positive, Her-2-Negative Breast Cancer: A Retrospective Single-Center Experience

T. Decker, R. Seifert, T. Dechow, 2021, Oncology Research and Treatment.

Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients

T. Decker, T. Winder, K. Geiger, 2022, Frontiers in Oncology.

Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patients

W. Jagla, A. Gaumann, T. Decker, 2021, Scientific Reports.

Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients

T. Decker, T. Winder, K. Geiger, 2023, Journal of Cancer Research and Clinical Oncology.